TTI-281

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTTI-281
Drug Alias Namefluorinated bromodomain 4 inhibitors (Fluorinov Pharma)FV-281TTI-281
ClassificationSmall molecules
Mechanisms of ActionBromodomain-containing protein 4 inhibitors
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFluorinov Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFluorinov Pharma IncTrillium Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A